TriSalus Life Sciences, Inc. (TLSI) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $344.78M; Retained Earnings (Accumulated Deficit)USD $-338.23M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $341.85M; Retained Earnings (Accumulated Deficit)USD $-329.04M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $4.00K; Additional Paid in CapitalUSD $296.72M; Retained Earnings (Accumulated Deficit)USD $-330.58M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $4.00K; Additional Paid in CapitalUSD $294.24M; Retained Earnings (Accumulated Deficit)USD $-320.97M.
TriSalus Life Sciences, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $5.00K | $344.78M | $-338.23M | $6.55M | (m) | 3 month · $2.62M | (m) |
| 2026-03-31 | $0.00 | $5.00K | $341.85M | $-329.04M | $12.81M | (m) | 3 month · $2.47M | (m) |
| 2025-12-31 | $0.00 | $4.00K | $296.72M | $-330.58M | $-33.86M | (m) | 12 month · $9.76M | (m) |
| 2025-09-30 | $0.00 | $4.00K | $294.24M | $-320.97M | $-26.73M | (m) | 3 month · $3.37M | (m) |
| 2025-06-30 | $0.00 | $3.00K | $278.79M | $-298.21M | $-19.42M | (m) | 3 month · $2.52M | (m) |
| 2025-03-31 | $0.00 | $3.00K | $255.55M | $-289.92M | $-34.37M | (m) | 3 month · $1.62M | (m) |
| 2024-12-31 | $0.00 | $3.00K | $253.65M | $-279.55M | $-25.89M | 12 month · $1.70M | 12 month · $5.44M | 12 month · $11.92M |
| 2024-09-30 | $0.00 | $3.00K | $249.00M | $-269.44M | $-20.43M | (m) | 3 month · $1.30M | (m) |
| 2024-06-30 | $0.00 | $2.00K | $241.78M | $-265.93M | $-25.26M | 3 month · $1.70M | 3 month · $1.27M | 3 month · $11.92M |
| 2024-06-26 | (m) | (m) | (m) | (m) | (m) | $1.70M | (m) | (m) |
| 2024-03-31 | $0.00 | $2.00K | $226.67M | $-261.60M | $-36.04M | (m) | 3 month · $1.09M | (m) |
| 2023-12-31 | $0.00 | $2.00K | $222.44M | $-249.50M | $-27.07M | (m) | 12 month · $1.40M | (m) |
| 2023-09-30 | $1.00K | $2.00K | $221.35M | $-212.87M | $8.29M | (m) | 3 month · $259.00K | (m) |
| 2023-06-30 | (m) | (m) | (m) | $-15.12M | $-198.42M | (m) | 3 month · $69.00K | (m) |
| 2023-03-31 | (m) | (m) | (m) | $-13.86M | $-184.52M | (m) | 3 month · $73.00K | (m) |
| 2022-12-31 | (m) | $0.00 | $10.03M | $-186.36M | $-177.13M | (m) | 12 month · $368.00K | (m) |
| 2022-09-30 | (m) | (m) | (m) | $-11.66M | $-153.93M | (m) | 3 month · $119.00K | (m) |
| 2022-06-30 | (m) | (m) | (m) | $-11.54M | $-145.96M | (m) | 3 month · $70.00K | (m) |
| 2022-03-31 | (m) | (m) | (m) | $-13.88M | $-137.35M | (m) | 3 month · $62.00K | (m) |
| 2021-12-31 | (m) | (m) | (m) | $-16.72M | $-129.60M | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | $-19.61M | $-19.61M | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | $5.70M | $-21.48M | $-21.48M | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | $6.08M | $-21.86M | $-21.86M | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $5.71M | $-21.49M | $-21.48M | 4 month · $13.64M | (m) | 4 month · $1.92M |
| 2020-12-22 | (m) | (m) | (m) | $-21.30M | $-21.30M | (m) | (m) | (m) |
| 2020-09-10 | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |